Latest Diabetes: Type II news
Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes
posted May 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Skyrizi Approved for Psoriatic Arthritis
Early Glycemic Control May Cut CV Risk in Type 2 Diabetes
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Add-On PPI Therapy May Improve Glycemic Control in Diabetes
Using New Guidelines Would Increase Diabetes Screening Eligibility
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anti-SSA, Anti-SSB Antibodies Low in RA Patients Wishing to Conceive
Hypertension, Arterial Stiffness Linked to Risk for Diabetes
posted May 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Age Impacts Outcomes After Ablation for Atrial Fibrillation
Editor's Recommendations
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Related Articles
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults Monthly Specialist Briefings
Stay Connected
